| RZLT Market Cap History Table | ||||||||||||||||||||||||||||||||||||||||||||||||
Below is a table of the RZLT market cap history going back to 10/13/2020:
Also see: RZLT Shares Outstanding History and RZLT YTD Return |
As of 5/8/2026 Rezolute has a market cap of 309.10 million. Investors often follow the RZLT market cap history to compare the size of the company over time.
This page shows RZLT market capitalization trends over time, with 23 market cap datapoints presented, dating back to 10/13/2020.

| RZLT Market Cap History Table | ||||||||||||||||||||||||||||||||||||||||||||||||
Below is a table of the RZLT market cap history going back to 10/13/2020:
Also see: RZLT Shares Outstanding History and RZLT YTD Return |
| RZLT Market Cap History Chart | |||||||||||||||||||||||||||||||||||||||||||||||||
RZLT Historical Market Cap: +15.34% CAGR
Mouse over chart for data details
| |||||||||||||||||||||||||||||||||||||||||||||||||
| RZLT Stock Price Chart |
| About Rezolute Inc |
| Rezolute, Inc. is a late-stage rare disease company, which is focused on improving outcomes for individuals with hypoglycemia caused by hyperinsulinism (HI). Its lead clinical asset, Ersodetug (formerly RZ358), is a potential treatment for hypoglycemia caused by multiple forms of hyperinsulinism including congenital HI and tumor HI. Ersodetug is an intravenously administered human monoclonal antibody that binds to a unique site (allosteric) on the insulin receptor in insulin target tissues, such as in the liver, fat, and muscle. Congenital is a rare pediatric genetic disorder characterized by excessive production of insulin by the pancreas. We show 23 historical shares outstanding datapoints in our RZLT shares outstanding history coverage, used to compute RZLT market cap on those dates. Understanding the changing numbers of shares outstanding, the changing share price, and the resulting changing RZLT market cap history over the course of time is important for investors interested in comparing RZLT's market cap history versus its peers. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies, and then calculating their respective market caps. Comparing the share price of RZLT versus a peer is one thing; comparing RZLT market cap versus a peer is a completely different story. Furthermore, via fluctuation both in per-share price and in the number of shares outstanding (via issuance of new shares over time, the repurchase of existing shares), the market cap for a company like RZLT can fluctuate over the course of history. With this page we aim to empower investors researching RZLT by allowing them to research the RZLT market cap history. |
| RZLT Current Stock Quote |
Quotes delayed 20 minutes Get Dividend Alerts Get SEC Filing Alerts |
| Video: The Importance of Market Cap | |
|
| RZLT Share Performance |
| Market Cap Peers |
| Rezolute (RZLT) is categorized under the Healthcare sector; to help you further research historical market cap numbers, below are some other companies in the same sector:
SABS Market Cap History SAGE Market Cap History SANA Market Cap History SAVA Market Cap History SBFM Market Cap History SBPH Market Cap History SBTX Market Cap History SCPH Market Cap History SCPS Market Cap History SCTL Market Cap History More Healthcare companies » |
Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 8.7%—Every Month—Forever.
You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 8.7%.